Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Response to Fake General Knowledge: Investigating the Eventual fate of artificial intelligence - 2NASA to bring astronauts home from space station early due to a medical issue
- 3Vote in favor of your Number one Kind of Shades
- 4Hundreds of Intact Dinosaur Eggs Emerge From 72-Million-Year Time Capsule
- 5Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract
- Carnival fever hits Lagos as locals celebrate Afro-Brazilian heritage
- ONE returns to Red Sea with new service
- Pick Your #1 breakfast food
- The Most Compelling Innovation Developments Somewhat recently
- Top 10 Smash hit Computer games of the Year
- Putin, Netanyahu discuss Middle East in phone call, Kremlin says
- Vote In favor of Your Favored Keeping an eye on
- Eight Muslim nations condemn Israel's 'dangerous' new death penalty law
- Europe picks companies to help build Argonaut moon lander
